1. Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis

   • Renaud Sabatier
   • Elise Lavit
   • Patrice Viens

   Original Article 01 February 2016 Pages: 497 - 506

   

2. BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population

   • Henriette Roed Nielsen
   • Mef Nilbert
   • Christina Therkildsen

   Original Article 01 February 2016 Pages: 507 - 512

   

3. Modeling the dyadic effects of parenting, stress, and coping on parent–child communication in families tested for hereditary breast-ovarian cancer risk

   • Jada G. Hamilton
   • Darren Mays
   • Kenneth P. Tercyak

   Original Article 05 February 2016 Pages: 513 - 522

   

4. No evidence of increased breast cancer risk for proven noncarriers from BRCA1 and BRCA2 families

   • Henriette Roed Nielsen
   • Janne Petersen
   • Anne-Bine Skytte

   Original Article 07 March 2016 Pages: 523 - 528

   

5. Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer

   • Aryana S. Jacobs
   • Marc D. Schwartz
   • Beth N. Peshkin

   Original Article 11 March 2016 Pages: 529 - 539

   

6. Angelina and Brad effect

   • Francois Eisinger

   Letter to the Editor 03 May 2016 Pages: 541 - 542

7. Decentralized colonoscopic surveillance with high patient compliance prevents hereditary and familial colorectal cancer

   • Olle Sjöström
   • Lars Lindholm
   • Beatrice Melin

   Original Article Open access 02 March 2016 Pages: 543 - 551

   

8. Rapid detection of germline mutations for hereditary gastrointestinal polyposis/cancers using HaloPlex target enrichment and high-throughput sequencing technologies

   • Masakazu Kohda
   • Kensuke Kumamoto
   • Yasushi Okazaki

   Original Article 02 February 2016 Pages: 553 - 562

   

9. Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers

   • Z. Ghorbanoghli
   • M. H. Nieuwenhuis
   • J. T. Wijnen

   Original Article Open access 15 February 2016 Pages: 563 - 570

   

10. MSI detection and its pitfalls in CMMRD syndrome in a family with a bi-allelic MLH1 mutation

    • Aurélia Nguyen
    • Gaelle Bougeard
    • Natacha Entz-Werle

    Short Communication 26 March 2016 Pages: 571 - 577

    

11. CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome

    • Aysel Ahadova
    • Magnus von Knebel Doeberitz
    • Matthias Kloor

    Original Article 09 March 2016 Pages: 579 - 586

    

12. Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency

    • Maureen E. Mork
    • Ester Borras
    • Eduardo Vilar

    Short Communication 26 March 2016 Pages: 587 - 591

    

13. Undefined familial colorectal cancer and the role of pleiotropism in cancer susceptibility genes

    • Sara E. Dobbins
    • Peter Broderick
    • Richard S. Houlston

    Original Article Open access 29 June 2016 Pages: 593 - 599

14. A mutation of the succinate dehydrogenase B gene in a Korean family with paraganglioma

    • Borum Sagong
    • Young Joon Seo
    • In Seok Moon

    Original Article 01 February 2016 Pages: 601 - 606

    

15. Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma

    • Roeliene C. Kruizinga
    • Denise M. S. van Marion
    • Annemiek M. E. Walenkamp

    Original Article Open access 26 February 2016 Pages: 607 - 616

    

16. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India

    • Manjunath Goroshi
    • Tushar Bandgar
    • Nalini S. Shah

    Original Article 23 February 2016 Pages: 617 - 624

17. MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics

    • Jessica Oliboni Scapineli
    • Lucieli Ceolin
    • Ana Luiza Maia

    Original Article 26 February 2016 Pages: 625 - 633

    

18. Evaluation of TP53 Pro72Arg and MDM2 SNP285–SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations

    • Francesca Ponti
    • Serena Corsini
    • Luca Sangiorgi

    Original Article 08 March 2016 Pages: 635 - 643

19. Ventricular fibrillation resulting from electrolyte imbalance reveals vipoma in MEN1 syndrome

    • Tiziana Cavalli
    • Francesco Giudici
    • Francesco Tonelli

    Original Article 12 April 2016 Pages: 645 - 649

    

20. Increased incidence of bladder cancer, lymphoid leukaemia, and myeloma in a cohort of Queensland melanoma families

    • Jazlyn Read
    • Judith Symmons
    • Nicholas K. Hayward

    Original Article 23 April 2016 Pages: 651 - 663

    

21. An investigation of the factors effecting high-risk individuals’ decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC)

    • Nina Hallowell
    • Shirlene Badger
    • Julia Lawton

    Original Article 02 June 2016 Pages: 665 - 676

22. Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families

    • Janice P. Dutcher
    • Peter H. Wiernik
    • Rangaswamy Chintapatla

    Original Article 22 June 2016 Pages: 677 - 687

23. Evaluation of laboratory perspectives on hereditary cancer panels

    • Jessica Stoll
    • Scott M. Weissman
    • Kristen J. Vogel Postula

    Original Article 11 February 2016 Pages: 689 - 696

24. Communicating genetic test results within the family: Is it lost in translation? A survey of relatives in the randomized six-step study

    • Mary B. Daly
    • Susan Montgomery
    • Karen Ruth

    Original Article Open access 20 February 2016 Pages: 697 - 706

    

25. A model for patient-direct screening and referral for familial cancer risk

    • Kristin B. Niendorf
    • Melissa A. Geller
    • Robert D. Madoff

    Original Article 27 June 2016 Pages: 707 - 716